stockrow
Friday 6 November 2026
Export EWTX’s income statement to Excel — free account
Edgewise Therapeutics, Inc.
EWTX Healthcare Biotechnology
- EPS
- +2,846.5%
- Free cash flow
- −30.2%
Quarter to September 2026, against a year earlier
44.89
6.02
+15.49%
Follow EWTX
Alert me
Edgewise Therapeutics, Inc. (EWTX) Shares outstanding
Edgewise Therapeutics, Inc.'s shares outstanding at the end of fiscal 2025 was $102.9M, up 11.4% from $92.4M in fiscal 2024. At the end of the quarter to 30 September 2026 it was $120.9M. Over the past ten years it has ranged from $739.0K (fiscal 2020) to $102.9M (fiscal 2025) — the current reading is the highest in ten years. Edgewise Therapeutics, Inc. ranks 131st of 600 Biotechnology companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $102.9M | 11.38% |
| FY2024 | $92.4M | 45.02% |
| FY2023 | $63.7M | 18.90% |
| FY2022 | $53.6M | 42.82% |
| FY2021 | $37.5M | 4,977.94% |
| FY2020 | $739.0K | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $120.9M | 12.26% |
| Jun 2026 | $107.7M | 0.52% |
| Mar 2026 | $107.1M | 4.07% |
| Dec 2025 | $102.9M | (2.43%) |
| 23 more quarters | Free account |
Against its own ten years
Low $739.0K
High $102.9M
Ten-year median
$58.7M
Current reading's percentile
100
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| IOVA Iovance Biotherapeutics, Inc. compare | $450.2M |
| ABCL AbCellera Biologics Inc. compare | $305.6M |
| RLAY Relay Therapeutics, Inc. compare | $202.8M |
| LEGN Legend Biotech Corporation Sponsored ADR compare | $193.8M |
| TNGX Tango Therapeutics, Inc. compare | $149.9M |
| ARQT Arcutis Biotherapeutics, Inc. compare | $135.9M |
| DFTX Definium Therapeutics, Inc. compare | $110.7M |
| EWTX Edgewise Therapeutics, Inc. | $107.7M |
| XENE Xenon Pharmaceuticals Inc. compare | $99.6M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item